114 related articles for article (PubMed ID: 38266312)
1. ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling.
Zhou C; Ma H; Yu W; Zhou Y; Zhang X; Meng Y; Chen C; Zhang J; Shi G
Biochem Biophys Res Commun; 2024 Feb; 698():149543. PubMed ID: 38266312
[TBL] [Abstract][Full Text] [Related]
2. ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation.
Yang S; Zhou L; Reilly PT; Shen SM; He P; Zhu XN; Li CX; Wang LS; Mak TW; Chen GQ; Yu Y
Cell Death Dis; 2016 Feb; 7(2):e2082. PubMed ID: 26844697
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program.
Labbé DP; Zadra G; Yang M; Reyes JM; Lin CY; Cacciatore S; Ebot EM; Creech AL; Giunchi F; Fiorentino M; Elfandy H; Syamala S; Karoly ED; Alshalalfa M; Erho N; Ross A; Schaeffer EM; Gibb EA; Takhar M; Den RB; Lehrer J; Karnes RJ; Freedland SJ; Davicioni E; Spratt DE; Ellis L; Jaffe JD; DʼAmico AV; Kantoff PW; Bradner JE; Mucci LA; Chavarro JE; Loda M; Brown M
Nat Commun; 2019 Sep; 10(1):4358. PubMed ID: 31554818
[TBL] [Abstract][Full Text] [Related]
4. ANP32B promotes lung cancer progression by regulating VDAC1.
Li T; Wang N; Li S; Yan H; Gao S; Gao W; Xu R
Gene; 2023 Apr; 859():147200. PubMed ID: 36642319
[TBL] [Abstract][Full Text] [Related]
5. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes.
Ma L; Wang J; Zhang Y; Fang F; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Sang X; Zhang K; Lu L; Wan X; Chen Y; Yu J; Zhuo R; Wu S; Lu J; Pan J; Hu S
Cancer Biol Ther; 2022 Dec; 23(1):1-15. PubMed ID: 36170346
[TBL] [Abstract][Full Text] [Related]
6. SHCBP1 regulates STAT3/c-Myc signaling activation to promote tumor progression in penile cancer.
Mo M; Tong S; Yin H; Jin Z; Zu X; Hu X
Am J Cancer Res; 2020; 10(10):3138-3156. PubMed ID: 33163262
[TBL] [Abstract][Full Text] [Related]
7. ANP32B promotes colorectal cancer cell progression and reduces cell sensitivity to PRAP1 inhibitor through up-regulating HPF1.
Yang LL; Li M; Huang W; Ren PT; Yan QH; Hao YH
Heliyon; 2024 Jan; 10(1):e23829. PubMed ID: 38192816
[TBL] [Abstract][Full Text] [Related]
8. DDX52 knockdown inhibits the growth of prostate cancer cells by regulating c-Myc signaling.
Yu W; Ma H; Li J; Ge J; Wang P; Zhou Y; Zhang J; Shi G
Cancer Cell Int; 2021 Aug; 21(1):430. PubMed ID: 34399732
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the PP2A activity by the histone chaperone ANP32B is long-range allosterically regulated by respiratory cytochrome c.
Rivero-Rodríguez F; Díaz-Quintana A; Velázquez-Cruz A; González-Arzola K; Gavilan MP; Velázquez-Campoy A; Ríos RM; De la Rosa MA; Díaz-Moreno I
Redox Biol; 2021 Jul; 43():101967. PubMed ID: 33882408
[TBL] [Abstract][Full Text] [Related]
10. Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation.
Faskhoudi MA; Molaei P; Sadrkhanloo M; Orouei S; Hashemi M; Bokaie S; Rashidi M; Entezari M; Zarrabi A; Hushmandi K; Mirzaei S; Gholami MH
Pathol Res Pract; 2022 May; 233():153851. PubMed ID: 35339914
[TBL] [Abstract][Full Text] [Related]
11. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
[TBL] [Abstract][Full Text] [Related]
12. Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
Li J; Wan F; Zhang J; Zheng S; Yang Y; Hong Z; Dai B
Mol Carcinog; 2023 Jul; 62(7):940-950. PubMed ID: 37036190
[TBL] [Abstract][Full Text] [Related]
13.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
14. ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice.
Yang Q; Liu HR; Yang S; Wei YS; Zhu XN; Zhi Z; Zhu D; Chen GQ; Yu Y
Cancer Sci; 2023 Jul; 114(7):2882-2894. PubMed ID: 37137487
[TBL] [Abstract][Full Text] [Related]
15. The histone chaperone ANP32B regulates chromatin incorporation of the atypical human histone variant macroH2A.
Mandemaker IK; Fessler E; Corujo D; Kotthoff C; Wegerer A; Rouillon C; Buschbeck M; Jae LT; Mattiroli F; Ladurner AG
Cell Rep; 2023 Oct; 42(10):113300. PubMed ID: 37858472
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
Ohno Y; Koizumi M; Nakayama H; Watanabe T; Hirooka M; Tokumoto Y; Kuroda T; Abe M; Fukuda S; Higashiyama S; Kumagi T; Hiasa Y
PLoS One; 2017; 12(5):e0177343. PubMed ID: 28486557
[TBL] [Abstract][Full Text] [Related]
17. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of DEAD-box RNA helicase 52 (DDX52) suppresses the proliferation of melanoma cells in vitro and of nude mouse xenografts by targeting c-Myc.
Wang Q; Qian L; Tao M; Liu J; Qi FZ
Bioengineered; 2021 Dec; 12(1):3539-3549. PubMed ID: 34233596
[TBL] [Abstract][Full Text] [Related]
19. The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice.
Chemnitz J; Pieper D; Stich L; Schumacher U; Balabanov S; Spohn M; Grundhoff A; Steinkasserer A; Hauber J; Zinser E
Sci Rep; 2019 Mar; 9(1):4853. PubMed ID: 30890743
[TBL] [Abstract][Full Text] [Related]
20. Elevated Expression of NOP16 as a Novel Prognostic Biomarker of Prostate Cancer.
Yang T; Sun F; Zhang C; Wang Z; Yang K; Xu Y; Liu Q
Ann Clin Lab Sci; 2023 Jul; 53(4):587-597. PubMed ID: 37625836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
